1220886-29-2

Basic information

• Product Name: 4-BroMo-5-fluoro-2-nitro-benzoic acid Methyl ester
• Synonyms: 4-BroMo-5-fluoro-2-nitro-benzoic acid Methyl ester;Methyl 4-broMo-5-fluoro-2-nitrobenzoate;3-Bromo-2-fluoro-6-nitro-benzoic acid methyl ester
• CAS NO: 1220886-29-2
• Molecular Formula: C₈H₅BrFNO₄
• Molecular Weight: 278.0320032
• Mol File: 1220886-29-2.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 337.6±42.0 °C(Predicted)
• Appearance: /
• Density: 1.742±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 4-BroMo-5-fluoro-2-nitro-benzoic acid Methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BroMo-5-fluoro-2-nitro-benzoic acid Methyl ester(1220886-29-2)
• EPA Substance Registry System: 4-BroMo-5-fluoro-2-nitro-benzoic acid Methyl ester(1220886-29-2)

Safety Data

• Hazardous Substances Data: 1220886-29-2(Hazardous Substances Data)

Usage

General Description

4-Bromo-5-fluoro-2-nitro-benzoic acid methyl ester is a chemical compound with the molecular formula C8H6BrFNO4. It is a methyl ester derivative of 4-bromo-5-fluoro-2-nitrobenzoic acid, and it is commonly used in organic synthesis and pharmaceutical research. 4-BroMo-5-fluoro-2-nitro-benzoic acid Methyl ester is a yellow crystalline solid that is insoluble in water but soluble in organic solvents. It is primarily used as a building block in the synthesis of various pharmaceutical intermediates and other organic compounds. Additionally, 4-bromo-5-fluoro-2-nitro-benzoic acid methyl ester has potential applications in the field of medicinal chemistry and drug discovery due to its unique chemical structure and properties.

Upstream product

• 849758-12-9 methyl 4-bromo-3-fluorobenzoate 
• 1020717-99-0 4-bromo-5-fluoro-2-nitrobenzoic acid 
• 18107-18-1 diazomethyl-trimethyl-silane 
• 74-88-4 methyl iodide 
• 186581-53-3 diazomethane 
• 67-56-1 methanol 
• 153556-42-4 4-bromo-3-fluorobenzoic acid 

Downstream Products

• 83102-93-6 methyl 2-nitro-4-bromo-5-hydroxybenzoate 
• 1620239-30-6 2-amino-4-bromo-5-fluorobenzaldehyde 
• 1620239-32-8 ethyl 3-{[(benzyloxy)carbonyl]amino}-7-bromo-6-fluoroquinoline-2-carboxylate 
• 1620239-33-9 3-{[(benzyloxy)carbonyl]amino}-6-fluoro-7-vinylquinoline-2-carboxylic acid 
• 1620239-34-0 benzyl [(3S)-1-(3-{[(3-{[(benzyloxy)carbonyl]amino}-6-fluoro-7-vinylquinolin-2-yl)carbonyl]amino}pyridin-4-yl)piperidin-3-yl]carbamate 
• 213382-40-2 4-bromo-5-fluoro-2-nitrobenzaldehyde 
• 1256955-36-8 methyl 2-amino-4-bromo-5-methoxybenzoate 
• 1623120-79-5 2-amino-4-bromo-5-methoxybenzoic acid 
• 1300031-65-5 4-chloro-7-(3,5-dimethyl-1,2-oxazol-4-yl)-6-methoxy-3-nitroquinoline 

Relevant articles and documents

Topoisomerase Inhibitors Addressing Fluoroquinolone Resistance in Gram-Negative Bacteria

Since their discovery over 5 decades ago, quinolone antibiotics have found enormous success as broad spectrum agents that exert their activity through dual inhibition of bacterial DNA gyrase and topoisomerase IV. Increasing rates of resistance, driven lar

QUINAZOLINONES AS PARP14 INHIBITORS

The present invention relates to quinazolinones and related compounds which are inhibitors of PARP14 and are useful, for example, in the treatment of cancer and inflammatory diseases.

1,4-DISUBSTITUTED PYRIDAZINE DERIVATIVES AND THEIR USE FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS

The present invention provides a compound of formula IA or a pharmaceutically acceptable salt thereof; 5 (IA) a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.